CARDIFF ONCOLOGY INC

Cardiff Oncology’s amended partnership with Nerviano Medical unlocks onvansertib’s path to market, boosting collaboration, royalty structure, and Phase III milestones for RAS‑mutated colorectal cancer therapy.

Cardiff Oncology, Inc. is a San Diego-based biotech company dedicated to pioneering innovative cancer therapies and treatments, with a mission to serve Californians and make a meaningful impact on cancer care.

Cardiff Oncology, Inc. is a biotech company making significant strides in cancer treatment, with a recent patent for a groundbreaking metastatic colorectal cancer treatment, but faces financial challenges in translating its innovation into success.

Cardiff Oncology, a San Diego-based biotech company, is dedicated to pioneering innovative cancer therapies and treatments, offering new hope to patients and their families in the fight against cancer.